LUNA - SB-421a-006 - Clinical Trial
What is the Purpose of this Study?
If you join this study, you will go to the study clinic at least ten times over about twenty seven months. Most visits will last two days, but some visits may take three days if needed. You will be placed by chance into one of two groups. One group will receive the study medicine, and the other group will receive a sham injection, which looks like a real injection but has no medicine.
Retinitis Pigmentosa
Who Can Participate in the Study?
People can join this study if they are older than 8 years or are adults. Both of their eyes must show signs of a vision disease called retinitis pigmentosa. They also cannot have had eye injections in the past.
What is Involved?
This study is testing a new medicine called ultevursen. It is being studied to help people who have a vision disease called retinitis pigmentosa. This disease is caused by a specific genetic change called a USH2A exon 13 mutation. Researchers want to see if ultevursen can help slow down or improve vision loss in people with this condition.
Study Details
